Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 5 Thoracic 2 Genitourinary 2 Sarcoma 1 Lymphoid 1 Gynecologic 1 Gastrointestinal 1 CNS 1

Conditions

Meningeal Carcinomatosis 1 Breast Neoplasms 1 Brain Neoplasms 1

Interventions

Trastuzumab 20 Radiosurgery 15 Magnetic Resonance Spectroscopy 15 Capecitabine 14 Lapatinib 12 Radiotherapy 11 Specimen Handling 10 Cyclophosphamide 9 trastuzumab deruxtecan 8 Temozolomide 8 Docetaxel 8 Paclitaxel 7 Gemcitabine 6 Cisplatin 6 sacituzumab govitecan 5 Vinorelbine 5 Therapeutics 5 Spinal Puncture 5 Flow Cytometry 5 tucatinib 4 pembrolizumab 4 paclitaxel-Angiopep-2 conjugate 4 eribulin 4 Methotrexate 4 Irinotecan 4 Fluorodeoxyglucose F18 4 Dexamethasone 4 Bevacizumab 4 temsirolimus 3 pyrotinib 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Breast Neoplasms × Referral and Consultation × CNS × Clear all

NCT05286684 2026-03-18

Exo-LCR

Centre Oscar Lambret

Phase NA Completed

Breast Neoplasms, Meningeal Carcinomatosis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡